Clop ransomware group lists seatt##### on its leak site

• Ransomware group: Clop
• Country: United States
• Sector: Healthcare
• Announcement date: December 24, 2024

Clop ransomware group claims Seagen as victim

The biotechnology company Seagen has been listed on the leak site of the Cl0p ransomware group. According to the announcement made on December 24, 2024, the threat actors claim to have successfully targeted the organization. This development follows a pattern of activity often observed in modern cyber extortion campaigns where groups use dedicated leak sites to pressure organizations into meeting their demands.

Ransomware leak sites serve as a public platform for threat actors to announce their victims. In many instances, these groups employ a tactic known as double extortion. In a double extortion scheme, the attackers do not merely encrypt an organization's data to disrupt operations; they also exfiltrate sensitive information before the encryption process begins. The threat of releasing this stolen data publicly or selling it on the dark web provides the attackers with additional leverage to demand a ransom payment.

Details of the claimed attack

The Cl0p group has provided specific details regarding the method they allegedly used to access the organization's environment. The threat actors claim to have obtained data from the company through the use of Cleo software. This claim suggests that the vulnerability may have been located within a third-party file transfer application rather than the organization's primary internal infrastructure.

The group has stated that they are currently reaching out to the company regarding the incident. Furthermore, the attackers have provided a private chat channel intended for communication between the threat actors and the victim organization. This method allows the group to negotiate terms or provide proof of the breach through a controlled environment.

Information regarding the leaked data

Despite the announcement on the leak site, there is a notable lack of specific details regarding the contents of the alleged breach. The listing does not provide information regarding the nature of the leaked data, and no screenshots of the stolen files have been provided by the group. Additionally, there is no information available concerning the total size of the data or the specific number of files involved in the incident.

About Seagen

Seagen (formerly Seattle Genetics) is a biotechnology company that develops and commercializes innovative antibody-drug conjugates (ADCs) for the treatment of cancer. The company specializes in oncology and was acquired by Pfizer in 2023.

Analysis and industry implications

This incident may be part of the large-scale campaigns conducted by the Cl0p group, which exploit vulnerabilities in file transfer software. Given the methods described, it is possible that the attack originated from supply chain vulnerabilities, where an organization is compromised through a trusted third-party software provider.

Because the entity operates in the healthcare sector, any potential leak of patient privacy or sensitive personal data could lead to regulatory consequences under frameworks such as HIPAA. The exposure of such data might create secondary risks, including identity theft or targeted phishing attacks against employees and customers. In the healthcare industry, the protection of sensitive information is critical due to the high value of medical records on the black market.

To defend against such threats, organizations in this sector may need to review their data security processes and perform necessary notifications regarding potential data breaches. Common defensive steps for organizations facing these types of threats include implementing strict patch management for all software, especially file transfer tools, and maintaining robust monitoring of network traffic for unusual data exfiltration patterns. Additionally, a zero-trust architecture and comprehensive supply chain risk management can help mitigate the impact of vulnerabilities found in third-party applications.